The US drugmaker Eli Lilly has bowed to demands from Donald Trump by raising the prices of its weight-loss jab for UK ...

As the U.S. stock market navigates a landscape marked by record highs and fluctuating inflation expectations, investors are keenly observing economic indicators that could influence Federal Reserve ...

Eli Lilly announced the price hike from September following calls from President Donald Trump to increase European prices ...

This episode of Pharma Pulse discusses a new executive order to build a domestic API stockpile, Eli Lilly’s 170% price ...

Mounjaro, one of the UK’s most popular weight-loss jabs, is set to become more expensive for private patients after Eli Lilly ...

A major change to the price of Mounjaro is set to come into effect in the UK on September 1. Drug manufacturer Eli Lilly has ...

Eli Lilly said the increase brings the UK price in line with other European markets, though NHS availability will be ...

A major change to the price of one weight loss medication will come into effect in September - but will it affect who is eligible for the drug?

Eli Lilly partners with the Indiana Fever and YMCA to empower girls in basketball, removing barriers and promoting community engagement in sports.

Eli Lilly and Co (NYSE: LLY) has entered into a $1.3 billion deal with Superluminal Medicines to develop small-molecule drugs ...

Down here, I begin to think that we are too negative on it, but I am very upset with Lilly in the way they handled this, and ...

(Reuters) -Eli Lilly has signed a deal worth $1.3 billion with privately held Superluminal Medicines to discover and develop ...